Skip to main content

Pafolacianine Dosage

Applies to the following strengths: 3.2 mg/1.6 mL

Usual Adult Dose for Ovarian Cancer

0.025 mg/kg IV over 60 minutes, 1 to 9 hours prior to surgery

Comments:


Use: For intraoperative identification of malignant lesions in patients with ovarian cancer.

Renal Dose Adjustments

Mild to moderate renal impairment: No adjustment recommended
Severe renal impairment: Data not available

Liver Dose Adjustments

Mild to moderate hepatic dysfunction: No adjustment recommended
Severe hepatic dysfunction: Data not available

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

IV compatibility: Only compatible with Dextrose 5%; must be infused using a dedicated infusion line

General:

Monitoring:

Patient advice:

More about pafolacianine

Patient resources

Other brands

Cytalux

Professional resources

Other brands

Cytalux

Related treatment guides

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.